VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Prepaid Assets (2011 - 2026)

VivoSim Labs (VIVS) posted quarterly Prepaid Assets of $709000.0 for Q4 2025, down 22.34% year-over-year from $913000.0 in Q4 2024, and down 19.61% quarter-over-quarter from $882000.0 in Q3 2025.

VivoSim Labs (VIVS) Prepaid Assets (2011 - 2026) Analysis & Trends

VivoSim Labs' Prepaid Assets history runs 15 years deep, the most recent figure standing at $709000.0 for Q4 2025.

  • In Q4 2025, Prepaid Assets fell 22.34% year-over-year to $709000.0; the TTM figure through Dec 2025 stood at $709000.0 (down 22.34% YoY), while the FY2025 annual figure was $90000.0, down 64.84% from the prior year.
  • Prepaid Assets for Q4 2025 stood at $709000.0, down from $882000.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $1.0 million in Q1 2021, with the low at $90000.0 in Q1 2025.
  • The 5-year median for Prepaid Assets is $713000.0 (2022), against an average of $682200.0.
  • The sharpest annual moves came in 2021 and 2024: Prepaid Assets tumbled 71.71% in 2021, then surged 50.64% in 2024.
  • VivoSim Labs' Prepaid Assets stood at $902000.0 in 2021, then declined by 12.64% to $788000.0 in 2022, then climbed by 15.86% to $913000.0 in 2023, then changed by 0.0% to $913000.0 in 2024, then declined by 22.34% to $709000.0 in 2025.
  • Business Quant data shows VIVS's Prepaid Assets at $709000.0 in Q4 2025, $882000.0 in Q3 2025, and $592000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 VivoSim Labs 1.49 Mn 1.49 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 511,000.00
Mar 31, 2026 557,000.00
Dec 31, 2025 709,000.00
Sep 30, 2025 882,000.00
Jun 30, 2025 592,000.00
Mar 31, 2025 90,000.00
Dec 31, 2024 913,000.00
Sep 30, 2024 940,000.00
Jun 30, 2024 640,000.00
Mar 31, 2024 256,000.00
Dec 31, 2023 913,000.00
Sep 30, 2023 624,000.00
Jun 30, 2023 792,000.00
Mar 31, 2023 313,000.00
Dec 31, 2022 788,000.00
Sep 30, 2022 519,000.00
Jun 30, 2022 717,000.00
Mar 31, 2022 858,000.00
Dec 31, 2021 902,000.00
Sep 30, 2021 512,000.00